Skip to main content
Equibles
EAIQ logo

EAIQ · Eyeonix AIQ, Inc.

Track EAIQ — free

Use EAIQ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EAIQ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.98 +0.68 (+52.31%) At close · Nov 2
Rebalance outlook locked
Going-concern doubt — flagged Nov 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, there is substantial doubt regarding the Company’s ability to continue as a going concern.”
View the 10-Q filed Nov 12, 2026
Market Cap
$51.87M
Shares
26.19M
Volume · Nov 2 100 Avg daily vol (10 sessions) 854

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.98 Open$1.98 Day$1.98–1.98 Available close range$0.41–1.98 Avg vol 30d545 Short vol25% DataMar 2022–Nov 2026 Filing10-Q · Nov 12

The closing range uses available history since Jan 14, 2026; less than a full year is stored.

Latest documents

2026
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Going-concern doubt and ineffective disclosure controls

Eyeonix faces substantial going-concern doubt because liquidity cannot fund at least the next 12 months. Nine-month revenue was $83,700 and net loss $28,029, compared with $44,600 and $72,900; controls were ineffective at September 30, 2026.

Net loss $16.68K Diluted EPS $0.00
Read from the MD&A section
5 source passages
Eyeonix was incorporated to develop, build, operate and franchise casual eating establishments. At September 30, 2026, we had $70,958 in total assets, all current, $36,322 in current liabilities and a $2,075,227 accumulated deficit. Our current liquidity resources are not sufficient to fund the anticipated level of operations for at least the next 12 months from the date these consolidated financial statements were issued. We recognized $83,700 and $44,600 in revenues during the nine months ended September 30, 2026 and 2025, respectively, from providing digital marketing services. As a result of the above, we recognized net losses of $28,029 and $72,900 for the nine months ended September 30, 2026 and 2025, respectively. Based on that evaluation, our Principal Executive Officer and Principal Financial and Accounting Officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2026 due to the material weakness in our internal controls over financial reporting, including our failure to design and maintain formal accounting policies, processes, and controls to analyze, and account for complex transactions as well as a need for additional accounting personnel who have the requisite experience in SEC reporting regulation. Open the document at this passage
Nov 3
Current report 8-K
COMMAND HEALGRID acquisition would issue 30,600,000 shares

Eyeonix AIQ proposed to acquire COMMAND HEALGRID source code from Eyeonix Greece through its wholly owned subsidiary Eyeonix MedAIQ, issuing 30,600,000 common shares as consideration and assuming ongoing development; the transaction is expected to finalize this calendar year.

Other events
3 source passages
On October 30, 2026, Eyeonix MedAIQ, Inc., a Wyoming corporation and wholly owned subsidiary of Eyeonix AIQ, Inc. (the “Company”), entered into a Memorandum of Understanding (the “MOU”) with Eyeonix S.A., a company organized under the laws of Greece (“Eyeonix Greece”), regarding the proposed acquisition of the source code for the software known as COMMAND HEALGRID (the “Asset”), which was developed by Eyeonix Greece. Under the proposed transaction, Eyeonix Greece would transfer to Eyeonix MedAIQ all of its rights in the Asset, and Eyeonix MedAIQ would assume responsibility for the Asset’s ongoing development. As consideration, the Company would issue to Eyeonix Greece 30,600,000 shares of its common stock. The transaction is expected to finalize in this calendar year. Open the document at this passage
Oct 22
Current report 8-K Events of Oct 16
Director or officer change, or executive pay

Eyeonix AIQ, Inc. added Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors, effective immediately, at an Extraordinary Meeting of the Board of Directors.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
$45,663
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-46.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 50-day avg +45%
above
RSI (14) 62
neutral
MACD trend Positive
52-week position 100%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +98%
trailing
YTD return +108%
this year
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 1601%
annualized · 1-yr
Max drawdown −95%
past year
ATR 17.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
+45% Bullish
RSI (14)
62 Neutral
MACD trend
Positive Bullish
52-week position
100% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $2 · 100% Range high $2
vs 50-day avg +45%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Advertising Agencies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EAIQ
Eyeonix AIQ, Inc.
this stock
$51.87M — — — —
APP
AppLovin Corp
 $135.54B -39.3% +70.0% 27.5 3.3%
OMC
Omnicom Group Inc.
 $24.01B +9.0% +10.1% — 8.9%
TTD
Trade Desk, Inc.
 $7.41B -58.7% +18.5% 22.7 15.3%
WPP
WPP plc
 $5.99B +23.7% — — 0.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Volume
Short vol %
25%
As of
Sep 23, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 28, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$65.7K
Net income (FY)
$792
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 12, 2026
This year
6

Eyeonix faces substantial going-concern doubt because liquidity cannot fund at least the next 12 months. Nine-month revenue was $83,700 and net loss $28,029, compared with $44,600 and $72,900; controls were ineffective at September 30, 2026.

View
Exempt Offerings
Offering
Indefinite
Filed
Nov 9, 2026
View

Performance

5D 20D 120D MTD YTD
EAIQ +80.0% +98.0% — +52.3% +108.4%
SPY -1.7% -2.9% +1.9% -0.5% +10.3%
vs SPY +81.7% +100.9% — +52.8% +98.1%
Key facts CIK 1807689 Visit website Investor relations